Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medicaid Outcomes-Based Payment Model For Cell, Gene Therapy to Launch In 2025

Oct 13 2023

• By Cathy Kelly

Will All Of Biden's Drug Pricing Demos Advance If He's Not Re-Elected? • Source: Shutterstock

Related Content

Accelerated Approval Reforms Give US FDA More Power And Flexibility – With Some Gaps

Dec 21 2022

Medicaid ‘Price Verification’ Audit Proposal Aims To Promote Cell, Gene Therapy Rebate Concessions

May 25 2023

Medicare Will Test Payment Model For Accelerated Approvals To ‘Expedite’ Confirmatory Trials

Feb 15 2023

Cell And Gene Therapy Outcomes-Based Contracts In Medicaid Need ‘National’ Support,' HHS Says

Feb 15 2023

Additional Topics

United States Reimbursement Policy Gene Therapy Medicaid BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.